Ines G Alamo1, Kolenkode B Kannan1, Harry Ramos1, Tyler J Loftus1, Philip A Efron1, Alicia M Mohr2. 1. Department of Surgery and Center for Sepsis and Critical Illness Research, University of Florida College of Medicine, Gainesville, FL. 2. Department of Surgery and Center for Sepsis and Critical Illness Research, University of Florida College of Medicine, Gainesville, FL. Electronic address: alicia.mohr@surgery.ufl.edu.
Abstract
BACKGROUND: Propranolol has been shown previously to restore bone marrow function and improve anemia after lung contusion/hemorrhagic shock. We hypothesized that daily clonidine administration would inhibit central sympathetic outflow and restore bone marrow function in our rodent model of lung contusion/hemorrhagic shock with chronic stress. METHODS: Male Sprague-Dawley rats underwent 6 days of restraint stress after lung contusion/hemorrhagic shock during which the animals received clonidine (75 μg/kg) after the restraint stress. On postinjury day 7, we assessed urine norepinephrine, blood hemoglobin, plasma granulocyte colony stimulating factor, and peripheral blood mobilization of hematopoietic progenitor cells, as well as bone marrow cellularity and erythroid progenitor cell growth. RESULTS: The addition of clonidine to lung contusion/hemorrhagic shock with chronic restraint stress significantly decreased urine norepinephrine levels, improved bone marrow cellularity, restored erythroid progenitor colony growth, and improved hemoglobin (14.1 ± 0.6 vs 10.8 ± 0.6 g/dL). The addition of clonidine to lung contusion/hemorrhagic shock with chronic restraint stress significantly decreased hematopoietic progenitor cells mobilization and restored granulocyte colony stimulating factor levels. CONCLUSION: After lung contusion/hemorrhagic shock with chronic restraint stress, daily administration of clonidine restored bone marrow function and improved anemia. Alleviating chronic stress and decreasing norepinephrine is a key therapeutic target to improve bone marrow function after severe injury.
BACKGROUND:Propranolol has been shown previously to restore bone marrow function and improve anemia after lung contusion/hemorrhagic shock. We hypothesized that daily clonidine administration would inhibit central sympathetic outflow and restore bone marrow function in our rodent model of lung contusion/hemorrhagic shock with chronic stress. METHODS: Male Sprague-Dawley rats underwent 6 days of restraint stress after lung contusion/hemorrhagic shock during which the animals received clonidine (75 μg/kg) after the restraint stress. On postinjury day 7, we assessed urine norepinephrine, blood hemoglobin, plasma granulocyte colony stimulating factor, and peripheral blood mobilization of hematopoietic progenitor cells, as well as bone marrow cellularity and erythroid progenitor cell growth. RESULTS: The addition of clonidine to lung contusion/hemorrhagic shock with chronic restraint stress significantly decreased urine norepinephrine levels, improved bone marrow cellularity, restored erythroid progenitor colony growth, and improved hemoglobin (14.1 ± 0.6 vs 10.8 ± 0.6 g/dL). The addition of clonidine to lung contusion/hemorrhagic shock with chronic restraint stress significantly decreased hematopoietic progenitor cells mobilization and restored granulocyte colony stimulating factor levels. CONCLUSION: After lung contusion/hemorrhagic shock with chronic restraint stress, daily administration of clonidine restored bone marrow function and improved anemia. Alleviating chronic stress and decreasing norepinephrine is a key therapeutic target to improve bone marrow function after severe injury.
Authors: Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette Journal: Cell Date: 2006-01-27 Impact factor: 41.582
Authors: Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2015-07 Impact factor: 3.313
Authors: Letitia E Bible; Latha V Pasupuleti; Amy V Gore; Ziad C Sifri; Kolenkode B Kannan; Alicia M Mohr Journal: Surgery Date: 2015-07-21 Impact factor: 3.982
Authors: Tyler J Loftus; Andrew J Thomson; Kolenkode B Kannan; Ines G Alamo; Jessica K Millar; Jessica M Plazas; Elizabeth E Whitley; Philip A Efron; Alicia M Mohr Journal: Am J Surg Date: 2017-06-23 Impact factor: 2.565
Authors: Ines G Alamo; Kolenkode B Kannan; Letitia E Bible; Tyler J Loftus; Harry Ramos; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2017-04 Impact factor: 3.313
Authors: Elizabeth S Miller; Tyler J Loftus; Kolenkode B Kannan; Jessica M Plazas; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2019-06-14 Impact factor: 2.192
Authors: Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2018-03 Impact factor: 3.313
Authors: Tyler J Loftus; Elizabeth S Miller; Jessica K Millar; Kolenkode B Kannan; Ines G Alamo; Philip A Efron; Alicia M Mohr Journal: Am J Surg Date: 2019-02-21 Impact factor: 2.565
Authors: Lauren S Kelly; Jennifer A Munley; Erick E Pons; Kolenkode B Kannan; Camille G Apple; Chase W Thompson; Philip A Efron; Alicia M Mohr Journal: Surgery Date: 2022-06-04 Impact factor: 4.348
Authors: Elizabeth S Miller; Camille G Apple; Kolenkode B Kannan; Zackary M Funk; Philip A Efron; Alicia M Mohr Journal: Am J Surg Date: 2020-07-25 Impact factor: 2.565
Authors: Camille G Apple; Elizabeth S Miller; Tyler J Loftus; Kolenkode B Kannan; Hari K Parvataneni; Jennifer E Hagen; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2019-12-24 Impact factor: 2.192
Authors: Tyler J Loftus; Kolenkode B Kannan; Juan C Mira; Scott C Brakenridge; Philip A Efron; Alicia M Mohr Journal: Shock Date: 2020-10 Impact factor: 3.533